The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

Jan. 01, 2019
Applicants:

Khloris Biosciences, Inc., Saratoga, CA (US);

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Nigel G. Kooreman, The Hague, NL;

Joseph C. Wu, Palo Alto, CA (US);

Lynne A. Bui, Saratoga, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/12 (2015.01); A61K 35/28 (2015.01); A61K 35/35 (2015.01); A61K 35/545 (2015.01); A61K 35/33 (2015.01); A61K 39/39 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01); A61K 35/33 (2013.01); A61K 39/0005 (2013.01); A61K 39/39 (2013.01); A61P 35/00 (2018.01); A61K 2039/55516 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/55577 (2013.01); A61K 2039/585 (2013.01);
Abstract

In one embodiment, the application discloses a method for the treatment of cancer in a patient, the method comprises a vaccination of the patient with a vaccine, wherein the vaccine comprises an effective amount of mammalian pluripotent stem cells obtained from an embryonic source or obtained by reprogramming of somatic cells from the patient, wherein the vaccination comprising the step of administering a mammalian pluripotent stem cells to the patient in need thereof; and vaccine formulations for use in the treatment of cancer.


Find Patent Forward Citations

Loading…